Literature DB >> 2814923

Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy.

S Kumar1, J R Haigh, L E Rhodes, S Peaker, J A Davies, B E Roberts, M P Feely.   

Abstract

Control of oral anticoagulant therapy in outpatients is often unsatisfactory. The contribution of poor compliance with prescribed warfarin to unstable anticoagulant control was investigated prospectively using low-dose phenobarbitone as an indicator of compliance in 30 out-patients, 15 with stable and 15 with unstable control. Following entry to the study, there was no significant change in anticoagulation (p = 0.36) in the group with stable control. In the group who previously had unstable control, there was a significant change in INR (p = 0.0045) and anticoagulant control greatly improved. It appears that the considerable fluctuation in INR seen in many of the latter patients before the study was due to poor compliance and that entering them into the study modified their behavior. Two patients in this group who continued to have unstable anticoagulant control were shown to be poorly compliant using the phenobarbitone indicator. The results suggest that, in outpatients, poor compliance is the major cause of unstable anticoagulation with warfarin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2814923

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  17 in total

1.  A "two-step" educational approach for patients taking oral anticoagulants does not improve therapy control.

Authors:  Doris Barcellona; Paolo Contu; Francesco Marongiu
Journal:  J Thromb Thrombolysis       Date:  2006-12       Impact factor: 2.300

2.  Compliance-guided therapy : a new insight into the potential role of clinical pharmacologists.

Authors:  Alexia Blesius; Sylvie Chabaud; Michel Cucherat; Patrick Mismetti; Jean-Pierre Boissel; Patrice Nony
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  Measurement of patient compliance and the interpretation of randomized clinical trials.

Authors:  R Vander Stichele
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  The prediction of steady-state plasma phenobarbitone concentrations (following low-dose phenobarbitone) to refine its use as an indicator of compliance.

Authors:  T Pullar; S Kumar; H Chrystyn; P Rice; S Peaker; M Feely
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

5.  Should we just let the anticoagulation service do it? The conundrum of anticoagulation for atrial fibrillation.

Authors:  D B Matchar; G P Samsa; S J Cohen
Journal:  J Gen Intern Med       Date:  1996-12       Impact factor: 5.128

6.  A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management.

Authors:  D A Fitzmaurice; E T Murray; K M Gee; T F Allan; F D R Hobbs
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

7.  Warfarin anticoagulation: a survey of patients' knowledge of their treatment.

Authors:  S M Moran; N Fitzgerald; M Pope; M Madden; C J Vaughan
Journal:  Ir J Med Sci       Date:  2011-06-25       Impact factor: 1.568

Review 8.  Clinical utilization of the international normalized ratio (INR).

Authors:  R S Riley; D Rowe; L M Fisher
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

9.  Comparison of anticoagulant control among patients attending general practice and a hospital anticoagulant clinic.

Authors:  J P Pell; B McIver; P Stuart; D N Malone; J Alcock
Journal:  Br J Gen Pract       Date:  1993-04       Impact factor: 5.386

10.  Initial evaluation of low-dose phenobarbital as an indicator of compliance with antimalarial drug treatment.

Authors:  J Karbwang; W Fungladda; C E Pickard; S Shires; A Hay; M Feely
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.